Important Message for AZ&Me™ Website Visitor(s)     Read Message »

** Self-Service Tools **

Prescription Delivery Status:

  • You can check the status of your medication delivery by contacting our program at: (800) 292-6363. Select IVR prompt (2) “To check the status of your last fill request.”
  • If you’re unable to identify your delivery status utilizing the IVR, select the option to be connected to an AZ&Me team member who can provide additional assistance.

Place a Refill (non-refrigerated medications only):

  • You can place a refill for a patient already enrolled in the program by contacting our program at: (800) 292-6363. Select IVR prompt (1) to request a refill for a non-refrigerated medication.

COVID-19 Update:

At AstraZeneca, we view the safety and wellbeing of our patients as the highest priority. Our Program continues to monitor the COVID-19 pandemic and its related impacts and deploy appropriate actions to support patients. We will keep you apprised of all new actions deployed to ensure you have uninterrupted access to your medication.

  • This site is intended for US Consumers and Health Care Professionals only.

  • About AZ&ME Español AZ Affordability
  • AstraZeneca AZ&Me Prescription Savings Program

    Call Us: 1-800-AZandMe (1-800-292-6363)

  • Home
  • Program Overview
  • requirements
  • Are You Eligible?
  • Medicare Re-Enrollment
    • Medicare HCP Reenrollment Letter
    • Medicare Patient Reenrollment Letter
  • Consent Form
  • Resources & Downloads
    • Prescription Product List
    • Download an Application
    • Application Checklist
    • Product Distribution Information
    • Frequently Asked Questions
    • AZ&Me Brochure

Medicare Re-Enrollment


The attestation process for Medicare patients looking to re-enroll in the program for 2021 has expired. If you are an existing Medicare patient looking to reenroll in our program for 2021, please complete the enrollment form which can be found under Resources and Downloads.

Close Continue
  • Please see full Prescribing Information, including Boxed WARNING(S) for BRILINTA, BYDUREON BCise, KOMBIGLYZE XR, SYMLIN and XIGDUO XR.

  • You may report side effects related to AstraZeneca products by clicking here.

  • This information is intended for US consumers and health care professionals only.

  • BEVESPI AEROSPHERE, BRILINTA, BYDUREON BCise, BYETTA, CALQUENCE, DALIRESP, FARXIGA, FASENRA, FASLODEX, IMFINZI, IRESSA, KOMBIGLYZE XR, LOKELMA, LYNPARZA, ONGLYZA, PULMICORT FLEXHALER, QTERN, SYMBICORT, SYMLIN, TAGRISSO and XIGDUO XR are registered trademarks and BREZTRI AEROSPHERE, KOSELUGO, and AZ&Me are trademarks of the AstraZeneca group of companies. All other trademarks are the property of their respective owners.

  • Contact Us
  • Cookie Notice
  • Legal Notice
  • Privacy Notice
  • Site Map
  • AstraZeneca-US.com
  • ©2021 AstraZeneca. All rights reserved. 
    US-30191; US-33602; US-44017; US-49533 Last Updated 1/21